Role of fosaprepitant, a neurokinin Type 1 receptor antagonist, in morphine-induced antinociception in rats

about

Role of fosaprepitant, a neurokinin Type 1 receptor antagonist, in morphine-induced antinociception in rats

Item

http://www.wikidata.org/entity/Q41950284

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Role of fosaprepitant, a neuro ...... nduced antinociception in rats

@en

type

Item

label

Role of fosaprepitant, a neuro ...... nduced antinociception in rats

@en

prefLabel

Role of fosaprepitant, a neuro ...... nduced antinociception in rats

@en

P1476

Role of fosaprepitant, a neuro ...... nduced antinociception in rats

@en

P2093

Mayank Gautam

http://www.w3.org/2001/XMLSchema#string

Pranav Prasoon

http://www.w3.org/2001/XMLSchema#string

Rahul Kumar

http://www.w3.org/2001/XMLSchema#string

Saroj Kaler

http://www.w3.org/2001/XMLSchema#string

Shivani Gupta

http://www.w3.org/2001/XMLSchema#string

Subrata Basu Ray

http://www.w3.org/2001/XMLSchema#string

P2860

Peptide autoreceptors: does an autoreceptor for substance P exist?

Molecular mechanisms and regulation of opioid receptor signaling.

Animal models of nociception.

Central sensitization: implications for the diagnosis and treatment of pain.

Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance.

Pharmacokinetic evaluation of fosaprepitant dimeglumine

Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons

Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation

Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting.

P304

394-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0253-7613.186198

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27756950

http://www.w3.org/2001/XMLSchema#string

P932

4980927

http://www.w3.org/2001/XMLSchema#string